Researchers discovered something surprising about how the liver works: a special group of liver cells can do two opposite things at the same time when you’ve just eaten. Normally, scientists thought the liver either makes sugar (when you’re hungry) or stores fat (when you’ve eaten). But these newly discovered cells do both simultaneously, and they don’t respond well to insulin, the hormone that controls blood sugar. This finding was seen in mice and human liver cells, and the number of these unusual cells increased when mice ate a high-fat diet. This discovery could help explain why people develop insulin resistance and metabolic problems.
The Quick Take
- What they studied: Whether liver cells can perform two opposite metabolic functions (making glucose and making fat) at the same time, especially after eating
- Who participated: Normal mice with healthy livers, mice fed high-fat diets, and human liver cells grown in mice. The exact number of animals wasn’t specified in the abstract
- Key finding: A previously unknown population of liver cells located near blood vessel entrances can simultaneously make both glucose and fat when the body has just eaten, and these cells don’t respond normally to insulin signals
- What it means for you: This discovery may help scientists better understand why some people develop insulin resistance and metabolic disease. However, this is early-stage research in mice and human cells in the lab, so it’s too soon to know how to use this information for health decisions
The Research Details
Scientists used several advanced techniques to study liver cells in mice and humans. First, they examined individual liver cells using specialized genetic sequencing to see which genes were active in each cell. They also used imaging techniques (HCR RNA-FISH and PrimeFlow) to visually identify which cells were making specific proteins related to glucose and fat production. To understand how these cells respond to insulin, they performed euglycemic-hyperinsulinemic clamps—a test where they carefully controlled blood sugar and insulin levels to measure how cells respond to insulin signals. Finally, they used stable isotope tracing (adding special labeled versions of nutrients) combined with imaging to watch individual cells actually performing both glucose and fat production simultaneously.
This research approach is important because it moves beyond studying the liver as a whole organ and instead examines individual cells. Previous understanding was based on observing the liver’s overall behavior, which masked the fact that different cell populations might be doing different things. By looking at single cells, researchers can discover new cell types and understand how they contribute to metabolic disease. This level of detail is crucial for understanding why some people develop insulin resistance.
This research used multiple complementary techniques to confirm findings, which strengthens confidence in the results. The findings were validated in both mouse and human liver cells, suggesting the discovery may be relevant to humans. However, because this is a preprint (not yet peer-reviewed), the findings haven’t undergone formal scientific review. The study appears to be preliminary research that identifies a new phenomenon but doesn’t yet explain all the details about why these cells behave this way or what causes them to increase in high-fat diet conditions
What the Results Show
The main discovery is that a specific subset of liver cells located in the periportal region (near where blood enters the liver) simultaneously express genes for both gluconeogenesis (making glucose from non-carbohydrate sources) and de novo lipogenesis (making new fat) during the fed state (after eating). This contradicts the long-held belief that these two processes are mutually exclusive and occur at opposite times. The researchers confirmed this wasn’t just genetic expression but actual metabolic activity—these cells were genuinely performing both processes simultaneously. Additionally, these dual-function cells showed natural insulin resistance, meaning they didn’t respond normally to insulin signals that typically suppress glucose production after eating. This is particularly interesting because insulin resistance is a hallmark of metabolic disease and type 2 diabetes.
When mice were fed a high-fat diet, the number of these dual-positive hepatocytes (cells doing both functions) increased significantly. This suggests that the presence of these unusual cells may be linked to how the liver becomes dysfunctional in obesity and metabolic disease. The fact that these cells were also found in human liver tissue grown in mice indicates the discovery is likely relevant to human metabolism, not just mouse biology
This research fundamentally challenges decades of understanding about liver metabolism. The conventional model, taught in medical schools and textbooks, states that gluconeogenesis and lipogenesis are reciprocal processes controlled by insulin—one turns on when the other turns off. This discovery suggests that reality is more complex, with a specialized cell population that can simultaneously perform both functions. This doesn’t invalidate previous research but rather adds a new layer of complexity to our understanding of liver metabolism
The study doesn’t explain why these cells exist or what their biological purpose might be. It’s unclear whether these cells are beneficial, harmful, or simply a byproduct of how the liver is organized. The research doesn’t establish whether these cells cause insulin resistance or whether insulin resistance causes their appearance. The study is primarily descriptive—it identifies and characterizes a new cell type but doesn’t yet explain the mechanisms driving their behavior. Additionally, while human liver cells were studied, the experiments were conducted in laboratory settings and in mice, not in living humans, so direct translation to human health effects remains uncertain
The Bottom Line
At this stage, there are no direct health recommendations from this research. This is fundamental science that helps explain how the liver works, not clinical guidance. People should continue following established advice about maintaining healthy weight, eating balanced diets, and exercising regularly. Future research may lead to new treatments for insulin resistance and metabolic disease based on understanding these unusual liver cells, but that’s not yet available. Confidence level: This is preliminary research that requires further validation
This research is most relevant to people interested in understanding metabolic disease, insulin resistance, and obesity. Scientists and medical researchers studying liver function and type 2 diabetes should pay attention to these findings. People with metabolic syndrome, prediabetes, or type 2 diabetes may eventually benefit from treatments developed based on this research, but that’s years away. People with normal metabolism don’t need to change anything based on this discovery
This is basic research, not a treatment or intervention. There’s no timeline for personal health benefits. It typically takes 5-10+ years for fundamental discoveries like this to lead to clinical applications. The immediate value is in advancing scientific understanding, which may eventually lead to new diagnostic tests or treatments
Want to Apply This Research?
- Track liver health markers: Monitor fasting blood glucose, insulin levels, and liver enzyme tests (ALT, AST) if you have metabolic risk factors. Record these quarterly or as recommended by your healthcare provider to establish trends
- Focus on reducing high-fat food intake and increasing physical activity, as the study showed high-fat diets increase the problematic liver cells. Log daily meals and exercise to identify patterns and make gradual improvements
- If you have metabolic risk factors, work with your healthcare provider to monitor insulin sensitivity through periodic testing. Use the app to track weight, waist circumference, and metabolic markers over time to catch early signs of insulin resistance
This research is preliminary and has not yet undergone peer review. It describes basic science discoveries in mice and laboratory-grown human cells, not clinical findings in living humans. These findings do not constitute medical advice and should not be used to diagnose, treat, or prevent any disease. Anyone concerned about insulin resistance, metabolic disease, or liver health should consult with a qualified healthcare provider. This research may eventually lead to new treatments, but such applications are not yet available. Always discuss any health concerns or changes with your doctor before making decisions based on research findings
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.